News & Perspective

Jan 20, 2006

Jan 20, 2006

Report discourages use of antivirals for seasonal flu

Jan 20, 2005 (CIDRAP News) – Researchers who analyzed numerous clinical trials concluded that the two newest antiviral drugs for influenza, oseltamivir (Tamiflu) and zanamivir (Relenza), should not routinely be used against seasonal flu—a recommendation flatly rejected by the manufacturer of oseltamivir.

Feb 03, 2006

Feb 03, 2006

CDC: New test speeds detection of bird flu in humans

(CIDRAP News) – A new test developed by federal experts offers preliminary detection of H5 avian influenza in human patients in about 4 hours, compared with 2 to 3 days for other methods, government officials announced today.

May 16, 2007

May 16, 2007

Syndromic surveillance: faulty alarm system or useful tool?

(CIDRAP News) – At first glance, the Web page looks like an overhead shot of a fantastic game board: a map—identifiably Los Angeles—sprinkled with faceted roundels in a half-dozen colors.

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Jun 28, 2016

Jun 28, 2016

News Scan for Jun 28, 2016

Saudi MERS cases
2009 H1N1 origins in Mexico
WHO health emergency head
Strategic National Stockpile report

May 10, 2017

May 10, 2017

News Scan for May 10, 2017

MRSA bacteremia
WHO on Liberia probe
Zika vaccine trial
Senate confirms FDA head
Tularemia in Australia

Nov 07, 2019

Nov 07, 2019

News Scan for Nov 07, 2019

Takeda's dengue vaccine
Preventing pneumonia after cardiac arrest
Botulism and salt-cured fish
Southern Hemisphere flu vaccine protection
WHO, Johns Hopkins collaborate

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»